Previous 10 | Next 10 |
home / stock / sphrf / sphrf news
Pfizer sees $15 billion revenue from the Pfizer/BioNTech COVID vaccine in 2021 and it could completely change Pfizer’s revenue and earnings trajectory. Think about what this will do for BioNTech. The above revenues are for the “pandemic phase.” Pfizer/BioNTech may...
UK government scoops the US in authorizing the use of the Pfizer/BioNTech vaccine; roll out to commence next week. FDA and EU approval probably not far off. The Pfizer/BioNTech vaccine has first mover advantage. BioNTech stock could experience further gains at least in the short term....
Viraleze antiviral could be effective against SAS-CoV-2 and RSV. Boston Consulting Group is involved in positioning and marketing this preventative/early stage infection product. Viraleze has a fast-track to market in Europe based on antiviral activity, not efficacy of preventing COVI...
DEP-coupled remdesivir (right) is soluble. Source Starpharma I’m beginning to think that Starpharma (ASX:SPL) ( SPHRY ) (SPHRF) is showing signs of overnight success after 20 years of hard slog. The company’s core expertise is in dendrimer (nanoparticle) technology, with two ...
Prospects for treating early stage COVID-19 remain uncertain, with a host of monoclonal antibody products and Starpharma’s (OTCQX: SPHRY ) nasal SPL7013 antiviral spray vying for a role for prevention of infection and early treatment. Here I update on the latest developments with remdes...
Source BioWorld Dr Anthony Fauci has recently indicated that getting early-stage treatments for COVID-19 that prevent vulnerable people going on to be hospitalised is a key goal. While he mentioned monoclonal antibody products in development, he was quite vague other than to say that t...
A lot of small molecule anticancer drugs have significant downsides due to poor solubility (requiring detergent additives that are toxic) and serious side effects (due to the need for high dosing to make an effective dose). Starpharma's (OCTQX: OTCQX:SPHRY ) dendrimer delivery technology ((D...
The following slide deck was published by Starpharma Holdings Limited in conjunction with this Read more ...
NEW YORK , June 15, 2020 /PRNewswire/ -- Virtual Investor Conferences today announced the agenda for the upcoming Global Virtual lnvestor Conference, the leading proprietary investor conference series. Individual investors, institutional investors, advisors and analysts are invited ...
There are many levels to the coronavirus pandemic and a massive effort is underway to find a vaccine and treatments. Genetic Engineering News summarised 161+ candidates. The US clinical trials website indicates 1,915 trials underway using the keyword COVID-19 (June 3, 2020). The common c...
News, Short Squeeze, Breakout and More Instantly...
Starpharma Holdings Ltd Company Name:
SPHRF Stock Symbol:
OTCMKTS Market:
(NewsDirect) Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) CEO Dr Jackie Fairley speaks with Proactive from the ASX Small and Mid-Cap Conference March 2023. The company is focused on the development of pharmaceutical and medical products for unmet patient needs, including in the areas ...
NEW YORK , June 15, 2020 /PRNewswire/ -- Virtual Investor Conferences today announced the agenda for the upcoming Global Virtual lnvestor Conference, the leading proprietary investor conference series. Individual investors, institutional investors, advisors and analysts are invited ...